Drug Law Weekly

Biotest AG - Biotest increases its market share worldwide, announces ambitious targets for 2006

Breast Cancer - Study provides data for price-setting policies related to Herceptin in breast cancer therapy

British Columbia Center for Excellence in HIV/AIDS - HIV-infected drug users not on HAART have the lowest life expectancy of HIV/AIDS cohorts

British National Institute for Medical Research - Dendritic cells infected with Mycobacterium tuberculosis mutants induce immunity

CHU Laval Research Center, Quebec City - Alzheimer disease amyloid plaque suppressed by marrow-derived microglia

Cambrex Bio Science Walkersville, Inc. - Cambrix announces availability of Poietics normal peripheral blood leukopaks

Carrington Laboratories, Inc. - Carrington reports $5.3 million net loss for 2005

Center E Marquis, Rennes - Hepatocellular carcinoma treated by cisplatin and injection of I-131-lipiodol

Center for DNA Fingerprinting & Diagnostics, Hyderabad - New findings in the area of diagnostics detailed

Central Hospital of Mikkeli - Mammographically detected cancers may have better prognosis than non-screened cancers

Cleveland Clinic - Cleveland Clinic to host national symposium on quality measurement in healthcare

Cleveland Clinic Florida - Recent findings in diagnostics provide new insights

Cleveland Clinic Foundation - Aspirin and clopidogrel resistance is an emerging clinical entity

Cleveland Clinic Foundation - In hypertrophic obstructive cardiomyopathy, pulmonary vein antrum isolation is a therapeutic option

Columbia University, New York - Myocardial ischemic injury is modulated by receptor for advanced-glycation end products

Committee for Medicinal Products for Human Use - Committee for Medicinal Products for Human Use adopts multiple opinions

CompBenefits Corp. - Eye exams should begin at infancy

Corgenix Medical Corporation - Corgenix files 510(K) for AtherOx, a predictive cardiovascular diagnostic line

Crucell Holland BV - Monoclonal antibody cocktail neutralizes rabies virus isolates

CuraGen Corporation - CuraGen and TopoTarget announce initiation of first NCI-sponsored clinical trial with PXD101

Cutting Edge Information - Patient recruitment shown as an opportunity to shorten clinical trials

CytoPathfinder, Inc. - CytoPathfinder signs agreement for joint research of ophthalmic drug

Encysive Pharmaceuticals - Encysive Pharmaceuticals delays studies with TBC3711

Genentech, Inc. - Genentech and Biogen Idec submit supplemental biologics license application for further Rituxan use

Information Technology - Maxant Technologies receives U.S. FDA clearance to market MediPort integrated digital workstations

Injury Prevention - Few child safety seats made for obese young children

National Taiwan University Hospital - Researchers provide details of new studies and findings in the area of smallpox vaccines

Optimer Pharmaceuticals, Inc. - Optimer Pharmaceuticals initiates phase III trials of OPT-99 for gastroenteritis

Pharmion Corporation - Pharmion Corporation submits Vidaza new drug application supplement for IV administration

Quality Assurance - Joint Commission issues alert on dangerous tubing misconnections

Sorenson Medical - U.S. FDA approves Sorenson's release of ambulatory infusion pumps for pain management

U.S. Food & Drug Administration - Data advance knowledge in prion disease research

U.S. Food & Drug Administration - Method for DNA probe detection of Listeria in culture is improved

U.S. Food & Drug Administration - Method to measure mercury in carbon black has been developed

U.S. Food & Drug Administration - Sample preparation affects recovery of Salmonella from fruit

U.S. Food & Drug Administration - U.S. FDA tentatively approves a co-package of generic AIDS drugs

U.S. Military Vaccine Agency - Reverse-genetics is most rapid method to produce avian influenza vaccine

UNICEF - After two years of drought, Ethiopian children are facing new diseases